Loading market intelligence…
Computational biology, therapeutics and life sciences.
| Helix Discovery | Biotech | $36.1B | $483M | Growth |
| Cellular Atlas | Biotech | $16.3B | $204M | Series C+ |
| Cedar Bio | Biotech | $10.5B | $129M | Series C+ |
| Oak Bio | Biotech | $7.8B | $95M | Series B |
| Juniper Bio | Biotech | $6.2B | $75M | Series B |
| Aspen Bio | Biotech | $5.1B | $61M | Series A |
| 2026-09-12 | Helix Discovery | Growth | $348M | $36.1B | Alta Ridge Partners | Demo · Unverified |
| 2026-08-15 | Cellular Atlas | Series C+ | $147M | $16.3B | Redwood Partners | Demo · Unverified |
| 2025-07-12 | Helix Discovery | Series A | $111M | Not disclosed | Alta Ridge Partners | Demo · Unverified |
| 2026-07-18 | Cedar Bio | Series C+ | $93M | $10.5B | Signal Peak Capital | Demo · Unverified |
| 2026-05-04 | Oak Bio | Series B | $68M | $7.8B | Civic Innovation Fund | Demo · Unverified |
| Pacific Foundry Ventures | VC | 2 | Series A | San Francisco, CA |
| Northstar Ventures | VC | 2 | Growth | Palo Alto, CA |
| Frontier Works | VC | 2 | Series A | San Francisco, CA |
| Bayview Ventures | VC | 2 | Seed | Menlo Park, CA |
| Marin Family Partners | Family Office | 2 | Growth | Palo Alto, CA |
| 2026-09-12 | Helix Discovery | Growth | $348M | $36.1B | Alta Ridge Partners | Demo · Unverified |
| 2026-08-15 | Cellular Atlas | Series C+ | $147M | $16.3B | Redwood Partners | Demo · Unverified |
| 2026-07-18 | Cedar Bio | Series C+ | $93M | $10.5B | Signal Peak Capital | Demo · Unverified |
| 2026-05-04 | Oak Bio | Series B | $68M | $7.8B | Civic Innovation Fund | Demo · Unverified |
| 2026-04-07 | Juniper Bio | Series B | $54M | $6.2B | Cypress Capital | Demo · Unverified |
| Month | Capital (demo) |
|---|---|
| 2026-01 | No tracked rounds |
| 2026-02 | $38M |
| 2026-03 | $44M |
| 2026-04 | $54M |
| 2026-05 | $68M |
| 2026-06 | No tracked rounds |
| 2026-07 | $93M |
| 2026-08 | $147M |
| 2026-09 | $348M |